EZETIMIBA

ਉਤਪਾਦ ਝਲਕ

About EZETIMIBA

EZETIMIBA is a prescription medication used to lower low‑density lipoprotein cholesterol (LDL‑C) in adults with hypercholesterolemia. It is indicated for patients who require additional LDL‑C reduction when diet, exercise, and statin therapy alone are insufficient. The drug is administered orally once daily and is available in tablet form. EZETIMIBA is formulated to provide a consistent therapeutic effect while minimizing the need for frequent dosing adjustments. Patients should follow their healthcare provider’s instructions regarding dosage and monitoring of lipid levels.

Key Benefits & Uses

• Reduces LDL‑C levels effectively in patients with high cholesterol.
• Can be used in combination with statins or other lipid‑lowering agents.
• Offers a convenient once‑daily dosing schedule.

Active Ingredient & Action

The active ingredient in EZETIMIBA is ezetimibe, a selective cholesterol absorption inhibitor. Ezetimibe blocks the Niemann–Pick C1‑like 1 (NPC1L1) transporter in the small intestine, reducing the uptake of dietary and biliary cholesterol. This mechanism leads to a decrease in the amount of cholesterol delivered to the liver, prompting the liver to increase LDL‑C receptor activity and clear more LDL‑C from the bloodstream.

Important Notes

Patients should inform their healthcare provider of any other medications they are taking, as drug interactions may occur. Regular monitoring of lipid profiles is recommended to assess treatment efficacy. EZETIMIBA should be used under the supervision of a qualified healthcare professional, and patients should adhere to prescribed dosing schedules and lifestyle recommendations to achieve optimal results.